Literature DB >> 4533155

Platelet function abnormalities in the myeloproliferative disorders.

T Adams, L Schutz, L Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4533155     DOI： 10.1111/j.1600-0609.1974.tb00262.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN： 0036-553X


× No keyword cloud information.
  5 in total

1.  The ultrastructure of defective human platelets.

Authors:  J G White; J M Gerrard
Journal:  Mol Cell Biochem       Date:  1978-11-01       Impact factor: 3.396

2.  Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.

Authors:  H Ludwig; W Linkesch; H Gisslinger; E Fritz; H Sinzinger; T Radaszkiewicz; A Chott; R Flener; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  An altered platelet granule glycoprotein in patients with essential thrombocythemia.

Authors:  W J Booth; M C Berndt; P A Castaldi
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

4.  The possible value of platelet aggregation studies in patients with increased platelet number.

Authors:  F Fabris; M Randi; R Sbrojavacca; A Casonato; A Girolami
Journal:  Blut       Date:  1981-11

5.  Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases.

Authors:  B R Anger; E Seifried; J Scheppach; H Heimpel
Journal:  Klin Wochenschr       Date:  1989-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.